STOCK TITAN

Varex Imaging Corp Stock Price, News & Analysis

VREX Nasdaq

Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.

Varex Imaging Corporation (VREX) delivers critical x-ray components for medical diagnostics and industrial inspection systems worldwide. This page provides investors and industry professionals with a comprehensive resource for tracking the company's latest press releases, financial announcements, and strategic developments.

Find timely updates on quarterly earnings, new product launches, and partnerships that shape Varex's leadership in imaging technology. Our curated collection includes regulatory filings, manufacturing innovations, and market expansion updates across both medical and industrial segments.

Bookmark this page to monitor how Varex's advancements in digital detectors, x-ray tubes, and quality engineering impact global healthcare and industrial inspection markets. Check regularly for objective reporting on developments affecting the medical imaging supply chain and non-destructive testing solutions.

Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q3 FY2021 after market close on August 3, 2021. This will be followed by a conference call at 3:00 PM Mountain Time, which will be accessible via the company's website or through designated phone numbers for U.S. and non-U.S. callers. The call will be archived online, with a replay available from August 3rd to August 17th.

Varex specializes in X-ray imaging components, serving medical, industrial, and security sectors, with a workforce of approximately 2,000 globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
conferences earnings
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) has launched the LUMEN 4336W digital radiography detector, enhancing its product line with features prioritizing durability and convenience. This new detector features a robust design with an IP68 rating, ensuring water resistance for real-world applications. It emphasizes reliability through a simplified internal structure and incorporates wireless charging capabilities. Varex continues to guarantee high image quality, leveraging its expertise in X-ray imaging technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.65%
Tags
none
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) announced a partial redemption of $30 million from its $300 million 7.875% senior secured notes due 2027, effective July 15, 2021. The redemption price is set at 103% of the principal amount plus accrued interest since April 15, 2021. CFO Sam Maheshwari highlighted that improved financial performance is enabling debt reduction and decreased interest expenses, indicating a positive cash generation trend for the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
none
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) is set to present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:30 am ET. The company's CFO, Sam Maheshwari, will discuss Varex’s business and future prospects during the presentation. This event will be available via webcast, with replays accessible for 90 days on the company's website, vareximaging.com. Varex, headquartered in Salt Lake City, Utah, specializes in X-ray imaging components used in medical and industrial applications, boasting over 70 years of innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.29%
Tags
conferences
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) reported strong financial performance for 2QFY21, with revenues of $204 million, a 15% sequential increase, and a 3% year-over-year rise. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 35%. Net earnings were $0.08 per diluted share for GAAP and $0.35 for non-GAAP. Positive drivers included robust global sales of CT tubes and industrial digital detectors. Cash flow from operations reached $13 million, and cash and equivalents stood at $111 million by quarter end.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.84%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for Q2 of fiscal year 2021 on May 4, 2021, after market close. A conference call is scheduled for the same day at 3:00 p.m. Mountain Time, accessible through the company's website or via phone. Varex specializes in X-ray imaging components and has over 70 years of innovation, providing solutions for medical, industrial, and security imaging applications. The company employs around 2,000 people globally, reflecting its strong presence in the imaging sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
conferences earnings
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 1:10 pm ET. The company’s CFO, Sam Maheshwari, will discuss Varex’s business and future prospects. The presentation will be webcast and accessible on the company’s website, with replays available for 90 days. Varex specializes in designing and manufacturing X-ray imaging components, playing a crucial role in medical and industrial applications, with over 2,000 employees worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
conferences
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) reported its 1QFY21 financial results, showing revenues of $177 million, a 4% increase sequentially from 4QFY20. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 34%, reflecting a 580 basis points improvement due to cost reductions and a favorable product mix. GAAP net earnings were $(0.16) per diluted share, while non-GAAP earnings were $0.08. The outlook for 2QFY21 estimates revenues between $180 million and $200 million and non-GAAP earnings per diluted share between $0.05 and $0.25.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.9%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q1 FY2021 on February 4, 2021, after market close. A conference call is scheduled for 3:00 PM MT the same day, available via webcast on the company’s investor site and through designated phone numbers. The replay will be accessible until February 18, 2021. Varex Imaging specializes in X-ray imaging components, with over 70 years of innovation in medical, industrial, and security applications, employing about 2,000 staff globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.79%
Tags
conferences earnings
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will present at two virtual investor conferences in January 2021. The first is at the CJS Securities 21st Annual New Ideas for the New Year Conference on January 13, 2021, at 1:35 pm ET. The second presentation is at the Sidoti Winter 2021 Investor Conference on January 14, 2021, at 11:30 am ET. CFO Sam Maheshwari will discuss Varex's business and future prospects. Webcast links are available for both events, and replays will be accessible for 90 days on the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
conferences

FAQ

What is the current stock price of Varex Imaging (VREX)?

The current stock price of Varex Imaging (VREX) is $11.62 as of August 22, 2025.

What is the market cap of Varex Imaging (VREX)?

The market cap of Varex Imaging (VREX) is approximately 466.3M.
Varex Imaging Corp

Nasdaq:VREX

VREX Rankings

VREX Stock Data

466.28M
40.81M
1.66%
95.59%
3.11%
Medical Devices
Electronic Components, Nec
Link
United States
SALT LAKE CITY